Apex Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 541.760 million compared to TWD 497.862 million a year ago. Operating income was TWD 30.406 million compared to TWD 33.070 million a year ago. Net income was TWD 27.949 million compared to TWD 44.811 million a year ago. Basic earnings per share was TWD 0.28 compared to TWD 0.45 a year ago. Diluted earnings per share was TWD 0.26 compared to TWD 0.41 a year ago. For the half year, sales was TWD 1,066.694 million compared to TWD 968.317 million a year ago. Operating income was TWD 65.066 million compared to TWD 77.770 million a year ago. Net income was TWD 49.687 million compared to TWD 61.869 million a year ago. Basic earnings per share was TWD 0.5 compared to TWD 0.62 a year ago. Diluted earnings per share was TWD 0.46 compared to TWD 0.59 a year ago.